Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA
Published . Updated .
Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA MarketBeat
Directly affected
- MRNA Moderna
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA MarketBeat
Source: MarketBeat
Moderna (MRNA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.98% | still updating |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| Moderna (MRNA) | that day | +4.28% | final price |
| Moderna (MRNA) | the next day | +2.53% | still updating |
| Moderna (MRNA) | three days earlier | +3.68% | final price |
| Moderna (MRNA) | five days earlier | -1.83% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +0.87% | still updating |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.61% | still updating |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.10% | still updating |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Disclosure records for Moderna (MRNA) within two months of 17 Oct 2026
- Maria Elvira Salazar sell Moderna (MRNA) ($1,001 - $15,000). That is 23 days before publication, inside 30 days. The filing is listed beside the story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.”
- Rohit Khanna buy Moderna (MRNA) ($1,001 - $15,000). That is 43 days before publication, inside 60 days. The filing is listed beside the story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.”
- Donald J Trump buy Moderna (MRNA) ($1,001 - $15,000). That is 50 days before publication, inside 60 days. The filing is listed beside the story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.”
- Maria Elvira Salazar buy Moderna (MRNA) ($1,001 - $15,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.”
- Maria Elvira Salazar sell Moderna (MRNA) ($1,001 - $15,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA”
Companies mentioned with this story
- MRNA Moderna
Moderna (MRNA) is linked, with no stored direction, high confidence in the 17 Oct 2026 story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA.” Reason on file: The source item explicitly associated this symbol with the reported development
How “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA” reaches Moderna (MRNA)
The 17 Oct 2026 story “Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA” names Moderna (MRNA) because of this story.
For Moderna (MRNA), the reason on file says The source item explicitly associated this symbol with the reported development
Dates in the story, and the Moderna (MRNA) price range
MRNA traded between 168.05 and 242.18 across 20 sessions. The latest close on file is 226.88.
What the saved facts support for Moderna (MRNA)
26 out of 100Price not final
“Moderna, Inc. $MRNA Shares Sold by Banque Pictet & Cie SA” scores 26 out of 100. The score uses 1 sources, a +1.92% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.